Verastem (VSTM) Equity Ratio (2011 - 2026)
Verastem's quarterly Equity Ratio came in at 0.36 in Q1 2026, up 245.77% year-on-year from 0.1 in Q1 2025, and up 54.67% quarter-over-quarter from 0.23 in Q4 2025.
Verastem has reported Equity Ratio for 16 years, with the latest figure at 0.36 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 245.77% year-over-year to 0.36; the trailing twelve-month figure through Mar 2026 stood at 0.36 (up 245.77% YoY), and the FY2025 full-year result was 0.23, up 181.56% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.36, up from 0.23 in the prior quarter.
- The five-year high for Equity Ratio was 0.63 in Q1 2022, with the low at 0.28 in Q4 2024.
- Average Equity Ratio over 5 years is 0.27, with a median of 0.27 recorded in 2023.
- Year-over-year, Equity Ratio sank 221.39% in 2025 and surged 245.77% in 2026.
- Tracing VSTM's Equity Ratio over 5 years: stood at 0.5 in 2022, then declined by 23.14% to 0.38 in 2023, then sank by 174.25% to 0.28 in 2024, then jumped by 181.56% to 0.23 in 2025, then jumped by 54.67% to 0.36 in 2026.
- The last three Equity Ratio figures came in at 0.36 (Q1 2026), 0.23 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.36 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | 0.18 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -0.28 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | 0.20 |
| Dec 31, 2023 | 0.38 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.53 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.50 |
| Sep 30, 2022 | 0.57 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.63 |
| Dec 31, 2021 | 0.81 |
| Sep 30, 2021 | 0.86 |
| Jun 30, 2021 | 0.71 |
| Mar 31, 2021 | 0.75 |
| Dec 31, 2020 | 0.75 |
| Sep 30, 2020 | 0.60 |
| Jun 30, 2020 | 0.58 |
| Mar 31, 2020 | 0.59 |
| Dec 31, 2019 | 0.05 |
| Sep 30, 2019 | 0.11 |
| Jun 30, 2019 | 0.23 |
| Mar 31, 2019 | 0.36 |
| Dec 31, 2018 | 0.45 |
| Sep 30, 2018 | 0.59 |
| Jun 30, 2018 | 0.73 |
| Mar 31, 2018 | 0.56 |
| Dec 31, 2017 | 0.64 |
| Sep 30, 2017 | 0.65 |
| Jun 30, 2017 | 0.78 |
| Mar 31, 2017 | 0.79 |
| Dec 31, 2016 | 0.86 |
| Sep 30, 2016 | 0.93 |
| Jun 30, 2016 | 0.93 |
| Mar 31, 2016 | 0.94 |
| Dec 31, 2015 | 0.91 |
| Sep 30, 2015 | 0.91 |
| Jun 30, 2015 | 0.92 |
| Mar 31, 2015 | 0.93 |
| Dec 31, 2014 | 0.90 |
| Sep 30, 2014 | 0.91 |
| Jun 30, 2014 | 0.92 |
| Mar 31, 2014 | 0.94 |
| Dec 31, 2013 | 0.94 |
| Sep 30, 2013 | 0.96 |
| Jun 30, 2013 | 0.93 |
| Mar 31, 2013 | 0.96 |
| Dec 31, 2012 | 0.97 |
| Sep 30, 2012 | 0.97 |
| Jun 30, 2012 | 0.97 |
| Mar 31, 2012 | 0.97 |
| Dec 31, 2011 | -0.22 |